Improving TRS/OEE in Pharmaceutical Manufacturing

Écrit par Ravinder Singh

Mar 6, 2026

lire

In the pharmaceutical industry, improving Overall Equipment Effectiveness (OEE) is crucial for maintaining efficient production and meeting strict quality and regulatory requirements. Every minute of downtime or underperformance on a production line can result in costly delays and compromise the plant’s ability to meet market demand. Consequently, maximizing TRS is a strategic priority for plant managers and industrial leaders seeking to optimize their operations and reduce costs.

The causes of inefficiencies in pharmaceutical manufacturing can be multiple: frequent shutdowns, long changeovers, non-conforming product quality, etc. These factors directly impact TRS, thereby reducing productivity and leading to increased operational costs. For example, an unplanned machine stoppage can disrupt the entire line, which not only increases lead times but also the scrap rate, affecting overall profit margins.

To overcome these challenges, several levers can be activated. The adoption of continuous improvement methodologies, such as Lean Manufacturing, combined with shop floor digitalization, offers a path toward operational excellence. Through solutions like TeepTrak, factories can benefit from real-time OEE monitoring and performance tracking, analyze the causes of unplanned downtime, and obtain complete visibility into line efficiency. Tracking key metrics such as yield rate, availability, and technical performance is essential for identifying and eliminating bottlenecks.

A concrete example is that of a tablet production line in a pharmaceutical plant, where initial analysis revealed insufficient availability caused by frequent maintenance interruptions. By integrating TeepTrak solutions, the team was able to precisely measure downtime, implement an improvement plan, and track results continuously. After six months, the line recorded a 15% increase in its TRS, significantly reducing production costs and improving the ability to fulfill customer orders.

In conclusion, to launch a TRS/OEE improvement project, it is essential to identify priorities and focus on quick wins, such as reducing unplanned downtime. Establishing solid governance around these projects contributes to continuous and tangible performance improvements. By leveraging solutions such as TEEPTRAK solutions to digitalize your production, plant managers can not only optimize their efficiency but also strengthen their competitive position in the market.

FAQ

Question 1: How does OEE impact pharmaceutical manufacturing?

OEE or Overall Equipment Effectiveness measures the operational efficiency of equipment and directly influences productivity, quality, and production costs in pharmaceutical manufacturing.

Question 2: What are the common causes of low OEE in pharmaceutical manufacturing?

Production slowdowns, unplanned shutdowns, and quality defects are frequent causes that reduce OEE. Identifying and addressing these causes is essential for improving efficiency.

Question 3: Where should I start to improve my plant’s TRS/OEE?

Start with an analysis of performance data, identify the main bottlenecks, and implement solutions like TeepTrak to benefit from real-time visibility and effective tracking.

Recevez les dernières mises à jour

Pour rester informé(e) des dernières actualités de TEEPTRAK et de l’Industrie 4.0, suivez-nous sur LinkedIn et YouTube. Vous pouvez également vous abonner à notre newsletter pour recevoir notre récapitulatif mensuel !

Optimisation éprouvée. Impact mesurable.

Découvrez comment les principaux fabricants ont amélioré leur TRS, minimisé les temps d’arrêt et réalisé de réels gains de performance grâce à des solutions éprouvées et axées sur les résultats.

Vous pourriez aussi aimer…

Multi Plant OEE: How to Standardize Performance Across Your Manufacturing Sites

How to harmonize OEE measurement across multiple sites to enable reliable comparisons, share best practices, and drive continuous improvement across the group. Multi-plant OEE has become a major strategic issue for manufacturers operating in multiple locations. The question comes up systematically during management committee meetings: "[…]

0 Comments